Study on the influence of mCRP on the curative effect of herceptin on breast cancer.

Trial Profile

Study on the influence of mCRP on the curative effect of herceptin on breast cancer.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 21 May 2012

At a glance

  • Drugs Trastuzumab (Primary)
  • Indications Breast cancer
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 21 May 2012 Planned End Date changed from 1 Dec 2013 to 1 Jan 2013 as reported by Chinese Clinical Trial Register.
    • 08 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top